Hepatitis Drugs Market Analysis Forecast to 2020 by P&S Market Research

Global Hepatitis Drugs Market Size, Share, Development, 

Growth and Demand Forecast to 2020

Global Hepatitis Drugs Market Expected to Grow with 30% CAGR During 2015 – 

2020 

The global hepatitis drugs market was valued at $23,222.1 million in 2014, and it is expected to grow with a 

CAGR of 29.7% during 2015 - 2020. The global hepatitis drugs market is growing due to increasing incidences of 

hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and 

increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global 

hepatitis drugs market. 

Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness 

the fastest growth during the forecast period, with a CAGR of 30.7%. 

Explore Report with Detailed TOC on “Global Hepatitis Drugs Market” at: 

https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market 

The information and data in the publication “Global Hepatitis Drugs Market Size, Share, Development, Growth 

and Demand Forecast to 2020” represent the research and analysis of data from various primary and secondary 

sources. The bottom-top approach has been used to calculate the global market size by type and drugs. The 

market numbers for countries are obtained through top-down approach. P&S Market Research analysts and 

consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every 

value of data presented in this report. The company bases its primary research on discussions with prominent 

professionals and analysts in the industry, which is followed by informed and detailed, online and offline research. 

Ask for Sample Pages: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market/reportsample 

TABLE OF CONTENT 

Chapter 1. Research Scope & Methodology 

1.1 Market Definition 

1.2 Objective 

1.3 Market Scope 

1.3.1 Market breakdown by segment 

1.3.2 Market breakdown by geography 

1.4 Research Methodology and Sources 

© P&S Market Research. All rights reserved 2



Chapter 2. Executive Summary 

2.1 Key Findings 

2.2 Research Summary 

Chapter 3. Market Outlook 

3.1 Introduction 

3.2 Global Trend in Hepatitis Drugs Market 

3.2.1 Increasing number of collaborations and partnerships 

3.3 Factors Driving the Growth of the Market and its Impact on Market Forecast 

3.3.1 Increasing incidences of hepatitis 

3.3.2 Increasing support from government organizations 

3.3.3 Growing geriatric population 

3.3.4 Increasing R&D investments in hepatitis research and drug discovery 

3.3.5 Impact analysis of drivers on market forecast 

3.4 Factors Hindering the Market and its Impact on Market Forecast 

3.4.1 High capital expenditure 

3.4.2 Stringent regulatory requirements 

3.4.3 Impact analysis of restraints on market forecast 

Chapter 4. Global Hepatitis Drugs Market Size and Forecast (2011 – 2020) 

4.1 Global Hepatitis Drugs Market Breakdown by Type 

4.2 Global Hepatitis Drugs Market Breakdown by Geography 

Chapter 5. Global Hepatitis Drugs Market Breakdown by Type 

5.1 Hepatitis C Drugs Market 

5.1.1 Hepatitis C drugs market segmentation by region 

5.1.2 Hepatitis C drugs market segmentation by drugs 




5.2 Hepatitis B Drugs Market 

5.2.1 Hepatitis B drugs market segmentation by region 

5.2.2 Hepatitis B drugs market segmentation by drugs 

5.3 Hepatitis A Drugs Market 

5.3.1 Hepatitis A drugs market segmentation by region 

Chapter 6. Global Hepatitis Drugs Market Breakdown by 

Geography 

6.1 North America Hepatitis Drugs Market 

6.1.1 North America hepatitis drugs market breakdown by type 

6.1.2 North America hepatitis drugs market breakdown by country 

6.2 Europe Hepatitis Drugs Market 

6.2.1 Europe hepatitis drugs market breakdown by type 

6.2.2 Europe hepatitis drugs market breakdown by country 

6.3 Asia Hepatitis Drugs Market 

6.3.1 Asia hepatitis drugs market breakdown by type 

6.3.2 Asia hepatitis drugs market breakdown by country 

6.4 Rest of the World Hepatitis Drugs Market 

6.4.1 RoW hepatitis drugs market breakdown by type 

Chapter 7. Pipeline Drugs for Hepatitis 

Chapter 8. Drug Approval Process in the .S. and EU 

8.1 Drug approval process in the U.S. 

8.2 Drug Approval in the EU 

Chapter 9. Competitive Positioning and Market Share Analysis 

9.1 Porter's Five Forces of Competitive Position Analysis 

9.1.1 Bargaining power of buyers 




9.1.2 Bargaining power of suppliers 

9.1.3 Threat of new entrants 

9.1.4 Intensity of rivalry 

9.1.5 Threat of substitutes 

9.2 Global Hepatitis Drugs Market Share Analysis 

Chapter 10. Company Profiles and Strategic Developments 

10.1 Key Company Profiles 

10.1.1 Gilead Sciences Inc. 

10.1.1.1 Business overview 

10.1.1.2 Product and service offerings 

10.1.2 F. Hoffmann-La Roche Ltd 



10.1.3 Johnson & Johnson 


10.1.3.2 Product and services offerings 

10.1.4 Merck & Co., Inc. 



10.1.5 GlaxoSmithKline plc 



10.1.6 AbbVie Inc. 






10.1.7 Novartis AG 



10.1.8 Bristol-Myers Squibb Company 



10.1.9 Dynavax Technologies Corporation 



10.1.10 Mitsubishi Tanabe Pharma Corporation 



10.2 Strategic Developments in the Hepatitis Drugs Market 

10.2.1 Mergers & acquisitions 

10.2.2 Collaborations & partnerships 

10.2.3 Marketing authorization 

10.2.4 Product launch 

10.2.5 Application filling 

10.2.6 Pipeline newscast 

10.2.7 Others 

Chapter 11. Appendix 

11.1 List of Abbreviations 




Buy Report at: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market 

LIST OF TABLES 

TABLE 1 

TABLE 2 

SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION 

GLOBAL HEPATITIS DRUGS MARKET SNAPSHOT 

TABLE 3 MAJOR COLLABORATION AND PARTNERSHIPS IN HEPATITIS DRUGS MARKET (2015) 

TABLE 4 

TABLE 5 

DRIVERS FOR THE MARKET: IMPACT ANALYSIS 

RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS 

TABLE 6 GLOBAL HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020) 

TABLE 7 GLOBAL HEPATITIS DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020) 

TABLE 8 GLOBAL HEPATITIS C DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020) 

TABLE 9 GLOBAL HEPATITIS C DRUGS MARKET BREAKDOWN BY DRUGS, $M (2015–2020) 

TABLE 10 GLOBAL HEPATITIS B DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020) 

TABLE 11 GLOBAL HEPATITIS B DRUGS MARKET BREAKDOWN BY DRUGS, $M (2015 – 2020) 

TABLE 12 GLOBAL HEPATITIS A DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020) 

TABLE 13 NORTH AMERICA HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020) 

TABLE 14 NORTH AMERICA HEPATITIS DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015 – 

2020) 

TABLE 15 EUROPE HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020) 

TABLE 16 EUROPE HEPATITIS DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020) 

TABLE 17 ASIA HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020) 

TABLE 18 ASIA HEPATITIS DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020) 

TABLE 19 ROW HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020) 

TABLE 20 DRUGS UNDER DEVELOPMENT FOR CHRONIC HEPATITIS B, 2015 

TABLE 21 CLINICAL TRIAL STAGES OF HEPATITIS C DRUGS, 2015 




TABLE 22 

TABLE 23 

TABLE 24 

TABLE 25 

TABLE 26 

TABLE 27 

TABLE 28 

TABLE 29 

TABLE 30 

TABLE 31 

GILEAD SCIENCES INC.– KEY FACTS 

F. HOFFMANN-LA ROCHE LTD – KEY FACTS 

JOHNSON & JOHNSON – KEY FACTS 

MERCK & CO., INC. – KEY FACTS 

GLAXOSMITHKLINE PLC – KEY FACTS 

ABBVIE INC. – KEY FACTS 

NOVARTIS AG – KEY FACTS 

BRISTOL-MYERS SQUIBB COMPANY – KEY FACTS 

DYNAVAX TECHNOLOGIES CORPORATION KEY FACTS 

MITSUBISHI TANABE PHARMA CORPORATION - KEY FACTS 

Buy Report at: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market 

LIST OF FIGURES 

FIG 1 RESEARCH SCOPE FOR GLOBAL HEPATITIS DRUGS MARKET 

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL HEPATITIS DRUGS MARKET 

FIG 3 TYPES OF HEPATITIS 

FIG 4 MAJOR SYMPTOMS OF HEPATITIS 

FIG 5 DIAGNOTSIC PROCEDURES FOR HEPATITIS 

FIG 6 KEY DRUGS USED TO TREAT HEPATITIS B AND HEPATITIS C 

FIG 7 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION IN MAJOR COUNTRIES 

FIG 8 BASIC DRUG DEVELOPMENT PROCEDURE 

FIG 9 GLOBAL HEPATITIS DRUGS MARKET SIZE BY TYPE, $M (2014 – 2020) 

FIG 10 GLOBAL HEPATITIS DRUGS MARKET SIZE BY GEOGRAPHY, $M (2014 – 2020) 




FIG 11 GLOBAL HEPATITIS C DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 12 GLOBAL HEPATITIS C DRUGS MARKET SHARE, BY REGION (2014 AND 2020) 

FIG 13 GLOBAL HEPATITIS C DRUGS MARKET SIZE BY REGION, $M (2014 – 2020) 

FIG 14 GLOBAL HEPATITIS C DRUGS MARKET SIZE BY DRUGS, $M (2014 – 2020) 

FIG 15 GLOBAL HEPATITIS B DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 16 GLOBAL HEPATITIS B DRUGS MARKET SHARE, BY REGION (2014 AND 2020) 

FIG 17 GLOBAL HEPATITIS B DRUGS MARKET SIZE BY REGION, $M (2014 – 2020) 

FIG 18 GLOBAL HEPATITIS B DRUGS MARKET SIZE BY DRUGS, $M (2014 – 2020) 

FIG 19 GLOBAL HEPATITIS A DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 20 GLOBAL HEPATITIS A DRUGS MARKET SHARE, BY REGION (2014 AND 2020) 

FIG 21 GLOBAL HEPATITIS A DRUGS MARKET SIZE BY REGION, $M (2014 – 2020) 

FIG 22 GLOBAL HEPATITIS DRUGS MARKET SIZE, BY GEOGRAPHY 

FIG 23 NORTH AMERICA HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 24 NORTH AMERICA HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020) 

FIG 25 NORTH AMERICA HEPATITIS DRUGS MARKET SHARE, BY COUNTRY (2014 AND 2020) 

FIG 26 EUROPE HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 27 EUROPE HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020) 

FIG 28 EUROPE HEPATITIS DRUGS MARKET SHARE, BY COUNTRY (2014 AND 2020) 

FIG 29 ASIA HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 30 ASIA HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020) 

FIG 31 ASIA HEPATITIS DRUGS MARKET SHARE, BY COUNTRY (2014 AND 2020) 

FIG 32 ROW HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020) 

FIG 33 ROW HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020) 

FIG 34 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS 




FIG 35 MARKET SHARE OF KEY PLAYERS IN THE GLOBAL HEPATITIS DRUGS MARKET (2014) 

About P&S Market Research 

P&S Market Research is a market research company, which offers market research and consulting services for 

various geographies around the globe. We provide market research reports, industry forecasting reports, 

business intelligence, and research based consulting services across different industry/business verticals. 

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate 

forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through 

their interaction with leading companies of the concerned domain. We help our clients with B2B market research 

and assist them in identifying various windows of opportunity, and framing informed and customized business 

expansion strategies in different regions. 

Contact: 

Ms Abhishek 

Executive – Client Partner 

347, 5th Ave. #1402 

New York City, NY - 10016 

Toll-free: +1-888-778-7886 (USA/Canada) 

Email: enquiry@psmarketresearch.com 

Web: https://www.psmarketresearch.com

Hepatitis Drugs Market Analysis Forecast to 2020 by P&S Market Research

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?